News

23andMe has just introduced its first in-house drug licensed to a Spanish drug company named Almirall. The drug was designed to target inflammatory processes and autoimmune conditions. Read this brief report to learn more about the drug itself as well as 23andMe’s plans for the future in pharmacology.

MyHeritage, one of the major providers of at-home DNA testing, just introduced 9 new health reports that cover 3 new genetic risks, 5 carrier statuses, and a polygenic risk score for hypertension. Read this comprehensive guide to learn all about the new reports and discover how they can help you identify potential problems before they actually happen.

Ancestry, the most famous at-home DNA testing company, is adding two new testing solutions to its already impressive portfolio. These kits will provide users with health-related results based on their genetic signature and complement existing ancestry reports. Read more about the tests in this brief report.

Living DNA, one of the most famous providers of at-home ancestry DNA tests, has just released its first health-related screening solution. The test mainly focuses on illnesses and conditions caused by our lifestyle and teaches us how to improve our lives by adopting healthier habits. Read more in this short analysis.

23andMe, the most popular at-home DNA testing provider, recently announced the implementation of auto-populating family trees paired with a significant expansion of its Western Asian, South Asian, and North African regions. Read this comprehensive report to find out more about these changes and learn what they mean for 23andMe users.

MyHeritage has released an update for its Theory of Family Relativity feature to include new historical records, family trees, and genetic signatures that have been added into the company’s database after the initial launch. Read this brief report to learn more about the update and how it can help you understand your test results on a more profound level.

23andMe, Ancestry, and Helix have formed a Privacy Coalition and released a whitepaper outlining the best practices for managing sensitive genetic data obtained from their customers. Congress is also drafting a bill that would legislate the issue on a federal level. Read more in this comprehensive report.

23andMe has joined forces with The Michael J. Fox Foundation in efforts to provide further insight into Parkinson’s disease through a new tool called Fox DEN (Fox Insight Data Exploration Network) designed to use customer-reported data in 23andMe’s database and combine it with genetic information. Read more in this article.

MyHeritage has just announced the launch of its new health-related direct-to-customer DNA test that should complement the existing ancestry-only testing options. Read this short overview to learn more about the new product, from its current price to some of the benefits it adds to your genetic reports.

Ancestry.com is currently beta testing its new feature designed to connect personal DNA reports with family trees and provide its users with more information regarding their lineages and ethnicity profiles. Read all about this exciting new addition and find out how to test the beta version of ThruLines in this short report.